Found 50 matching trials
TACE vs TACE+SBRT for Unresectable Hepatocellular Cancer
PHASE2Vast majority of patients with hepatocellular carcinoma (HCC) present with ...
Location
Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre
Role of DEB-TACE Versus c-TACE in Treatment of HCC
EARLY_PHASE1Hepatocellular carcinoma (HCC) is listed as the sixth most common cancer wo...
Location
Sohag University Hospital
Drug-eluting Bead in Hepatocellular Carcinoma
PHASE4In unresectable hepatocellular carcinoma, TACE using Lipiodol/anti cancer a...
Location
Seoul National University Hospital
Transarterial Chemoembolization (TACE) Plus ABCB1 Inhibition Versus TACE Alone in Patients With Hepatocellular Carcinoma
PHASE2IMPACT-TACE is an investigator-initiated, prospective, multicenter, randomi...
Location
University Hospital Basel
Chemoembolization Using Doxorubicin in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
NARATIONALE: Drugs used in chemotherapy, such as doxorubicin, work in differe...
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Trial of Beads Versus Doxorubicin Eluting Beads for Arterial Embolization of Hepatocellular Carcinoma
PHASE2The purpose of this study is to evaluate the effect of blocking the blood v...
Location
Memorial Sloan Kettering Cancer Center
Study in the Treatment of HCC With a Radiopaque (RO) Bead (LC Bead LUMI™) Loaded With Doxorubicin
NAHepatocellular carcinoma (HCC) is the most common type of primary liver can...
Location
Multiple Locations
A Study of ONCO-DOX in Locally Advanced Hepatocellular Carcinoma
PHASE3This is a prospective, multicenter study that will be conducted at up to 40...
Location
University of Alabama Hospital
Observational Prospective Study on Chemoembolization With Doxorubicin for Unresectable Hepatocellular Carcinoma
N/AHepatocellular carcinoma (HCC) is the fifth most common type of cancer in m...
Location
Azienda Ospedaliera Ospedali Riuniti Marche Nord, Presidio Ospedaliero San Salvatore
Combined DEB-TACE, Lenvatinib and Pucotenlimab as Conversion Therapy for Unresectable Intrahepatic Cholangiocarcinoma
PHASE2This is an open-label, single-arm, phase 2 study. The purpose of study is t...
Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology